Stay updated on Emactuzumab and Atezolizumab Combination Clinical Trial
Sign up to get notified when there's something new on the Emactuzumab and Atezolizumab Combination Clinical Trial page.

Latest updates to the Emactuzumab and Atezolizumab Combination Clinical Trial page
- CheckyesterdayChange DetectedThe study record no longer lists a 2014 U.S. NIH grant/contract identifier. The site revision advances from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe ClinicalTrials.gov page now displays the study record for the emactuzumab and atezolizumab combination trial in advanced solid tumors, including its design, eligibility criteria, outcome measures, and historical updates.SummaryDifference52%

- Check22 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces NIH’s website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision indicator changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

Stay in the know with updates to Emactuzumab and Atezolizumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emactuzumab and Atezolizumab Combination Clinical Trial page.